000590 古汉医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.508-18.9833.5502.6275.348
总资产报酬率 ROA (%)-1.513-11.5932.1781.6973.811
投入资产回报率 ROIC (%)-1.826-14.1102.6442.0644.642

边际利润分析
销售毛利率 (%)46.66846.81552.42151.12355.277
营业利润率 (%)-5.510-49.1484.9826.46814.081
息税前利润/营业总收入 (%)-4.674-34.8717.8555.21311.822
净利润/营业总收入 (%)-6.700-37.0716.1515.17411.782

收益指标分析
经营活动净收益/利润总额(%)203.14022.93339.88371.63275.465
价值变动净收益/利润总额(%)-0.7250.4099.38712.6687.954
营业外收支净额/利润总额(%)2.743-38.10632.075-3.643-1.237

偿债能力分析
流动比率 (X)2.6542.1162.1691.9492.962
速动比率 (X)1.9471.5881.6461.5142.499
资产负债率 (%)38.04440.67336.74039.80429.500
带息债务/全部投入资本 (%)14.62116.08414.25816.1132.535
股东权益/带息债务 (%)499.853451.072532.133453.6483,359.071
股东权益/负债合计 (%)162.181145.140171.125150.362238.288
利息保障倍数 (X)-4.713-48.66315.094-5.070-5.662

营运能力分析
应收账款周转天数 (天)6.52615.30520.42612.6311.301
存货周转天数 (天)269.876251.328232.150215.184183.880